PerkinElmer Declares $.07 Dividend; ViaCell Deal Clears Waiting Period | GenomeWeb
NEW YORK (GenomeWeb News) — PerkinElmer’s bid to buy ViaCell has passed the Hart-Scott-Rodino antitrust waiting period, which expired yesterday.
 
Separately today, PerkinElmer declared a $.07 quarterly dividend payable on Feb. 8, 2008, to all stockholders of record at the end of Jan. 18, 2008.
 
The company is scheduled to release its quarterly earnings after the close of trading today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.